Consucon MR 60 mg is a modified-release oral antidiabetic medication produced by Incepta Pharmaceuticals Ltd. It contains Gliclazide, a second-generation sulfonylurea, used to manage Type 2 Diabetes Mellitus in adults when diet, exercise, and weight loss alone do not adequately control blood sugar levels.